Replies to post #70266 on Biotech Values

[rkrw]

If JP gets the whopper hiv deal he promised in *2008* in these last 2 weeks, I'd give him a lot more credit. Otherwise I don't see how much credit you can give him for the share price doubling after being depressed because he pushed an inferior hcv compound far too long. Plus he's been a bad neighbor in Cambridge with his loud machines :)

[RockRat]

I agree with you, for the additional reason that wile he might be a good diagnostics CEO, he ran one of the stupidest late stage trials I've ever seen: of Flurbiprofen in AD. It was obvious even to me that it should have been scrapped in P2, but no, he went to P3 based on a subset analysis of a subset analysis.

The award should probably go to Celgene's CEO Sol Barer. No, he and his stock haven't done that much THIS year, but the last decade . . .

Regards, RockRat